This website uses cookies

Some cookies are essential to the running of the website, while others (analytics) help us to make improvements. We also incorporate functionality from other websites, such as video, social media feeds and ReachDeck (text-to-speech and translations services) which may set cookies. More on how we use cookies

Set cookie preferences

Alert COVID-19

Please find service updates and current visiting rules in our COVID-19 section.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Paediatric solid tumours

Medulloblastoma Group 3/4 - Paediatric (M147) and other disease entities

  • Gain or amplification of MYCN FISH (M147.4)
  • Gain or amplification of MYC FISH (M147.5)
  • i(17q) / del(17p) FISH can also be performed if considered clinically relevant. This test may not be included in the TD for the disease entity, in which case the test will be invoiced separately. Please contact us to discuss further.

It may be clinically relevant to undertake these studies when there is a differential diagnosis of another tumour type and the results will aid patient management.

Midline Carcinoma - Paediatric (M151)

NUTM1 rearrangement FISH (M151.1); undertaken using a NUTM1 breakapart probe only, therefore partner gene is not identifiable

Oligodendroglioma - Paediatric (M156) and other disease entities

1p & 19q codeletion FISH (M156.5)

It may be clinically relevant to undertake these studies when there is a differential diagnosis of another tumour type and the results will aid patient management.

Last reviewed:02 August 2021